Karen Davidson

855 total citations
26 papers, 700 citations indexed

About

Karen Davidson is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Karen Davidson has authored 26 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in Karen Davidson's work include Epigenetics and DNA Methylation (5 papers), Telomeres, Telomerase, and Senescence (4 papers) and Cancer therapeutics and mechanisms (3 papers). Karen Davidson is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Telomeres, Telomerase, and Senescence (4 papers) and Cancer therapeutics and mechanisms (3 papers). Karen Davidson collaborates with scholars based in United States, United Kingdom and Japan. Karen Davidson's co-authors include Michael J. Hanley, Daniel D. Von Hoff, Elżbieta Izbicka, Michael P. Wilkie, Laura Forsyth, Bruce L. Tufts, R. A. Lawrence, B Forseth, Éric Raymond and Richard Lawrence and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Karen Davidson

24 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Davidson United States 15 344 123 121 106 88 26 700
David L. Lattier United States 22 479 1.4× 181 1.5× 72 0.6× 47 0.4× 131 1.5× 34 1.2k
Midori Hashimoto Japan 17 336 1.0× 230 1.9× 89 0.7× 41 0.4× 33 0.4× 50 981
Öztürk Özdemir Türkiye 16 284 0.8× 82 0.7× 105 0.9× 85 0.8× 31 0.4× 102 910
Darcey Black United Kingdom 10 161 0.5× 25 0.2× 187 1.5× 19 0.2× 107 1.2× 12 876
Cecil Hougie United States 22 190 0.6× 277 2.3× 25 0.2× 44 0.4× 39 0.4× 82 1.6k
Linus Chang Australia 21 409 1.2× 197 1.6× 74 0.6× 95 0.9× 12 0.1× 37 1.3k
P. De Angelis Norway 17 439 1.3× 54 0.4× 326 2.7× 182 1.7× 119 1.4× 37 1.3k
Taro Okazaki Japan 15 407 1.2× 114 0.9× 216 1.8× 83 0.8× 12 0.1× 71 849
T. Ishikawa Japan 15 568 1.7× 94 0.8× 125 1.0× 213 2.0× 33 0.4× 28 919
Florence Jouan France 14 396 1.2× 240 2.0× 100 0.8× 182 1.7× 21 0.2× 36 812

Countries citing papers authored by Karen Davidson

Since Specialization
Citations

This map shows the geographic impact of Karen Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Davidson more than expected).

Fields of papers citing papers by Karen Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Davidson. The network helps show where Karen Davidson may publish in the future.

Co-authorship network of co-authors of Karen Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Davidson. A scholar is included among the top collaborators of Karen Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Davidson. Karen Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Robert P., et al.. (2023). Scaled-up Synthesis and Characterization of Oxytocin Trisulfide. International Journal of Peptide Research and Therapeutics. 30(1). 2 indexed citations
2.
3.
Hammond, Lisa A., Karen Davidson, Richard Lawrence, et al.. (2001). Exploring the mechanisms of action of FB642 at the cellular level. Journal of Cancer Research and Clinical Oncology. 127(5). 301–313. 25 indexed citations
4.
Raymond, Éric, Sandrine Faivre, Geoffrey R. Weiss, et al.. (2001). Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas.. PubMed. 7(5). 1171–80. 36 indexed citations
5.
Davidson, Karen, et al.. (2001). C-kit mutation screening in patients with acute myeloid leukaemia: adaptation of a Giemsa-stained bone-marrow smear DNA extraction technique.. PubMed. 58(2). 76–84. 4 indexed citations
6.
Soda, Hiroshi, Éric Raymond, Sunil Sharma, et al.. (2000). Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro. The Prostate. 43(3). 161–168. 46 indexed citations
7.
Izbicka, Elżbieta, Ewa Sommer, Ewa Skopińska-Różewska, et al.. (2000). Tetracationic porphyrins inhibit angiogenesis induced by human tumor cells in vivo.. PubMed. 20(5A). 3205–10. 4 indexed citations
8.
Hidalgo, Manuel, Miguel A. Villalona‐Calero, S. Gail Eckhardt, et al.. (2000). Phase I and Pharmacologic Study of PN401 and Fluorouracil in Patients With Advanced Solid Malignancies. Journal of Clinical Oncology. 18(1). 167–167. 27 indexed citations
9.
Britten, Carolyn D., Elżbieta Izbicka, Susan G. Hilsenbeck, et al.. (1999). Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay. Cancer Chemotherapy and Pharmacology. 44(2). 105–110. 37 indexed citations
10.
Raymond, Éric, D. Sun, Elżbieta Izbicka, et al.. (1999). A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. British Journal of Cancer. 80(9). 1332–1341. 19 indexed citations
11.
Petit, Thierry, Karen Davidson, Elżbieta Izbicka, & Daniel D. Von Hoff. (1999). Elimination of extrachromosomal c-myc genes by hydroxyurea induces apoptosis. APOPTOSIS. 4(3). 163–167. 6 indexed citations
12.
Izbicka, Elżbieta, Karen Davidson, R. A. Lawrence, et al.. (1999). Cytotoxic effects of MGI 114 are independent of tumor p53 or p21 expression.. PubMed. 19(2A). 1299–307. 22 indexed citations
13.
Siu, Lillian L., Elżbieta Izbicka, R. A. Lawrence, et al.. (1998). Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units. Annals of Oncology. 9(8). 885–891. 24 indexed citations
14.
Davidson, Karen, Thierry Petit, Elżbieta Izbicka, Steven J. Koester, & Daniel D. Von Hoff. (1998). Mitoguazone induces apoptosis via a p53-independent mechanism. Anti-Cancer Drugs. 9(7). 635–640. 13 indexed citations
15.
Sharma, Sunil, Éric Raymond, Hiroshi Soda, et al.. (1998). Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leukemia Research. 22(8). 663–670. 20 indexed citations
16.
Izbicka, Elżbieta, Richard Lawrence, Karen Davidson, James Rake, & Daniel D. Von Hoff. (1998). Effects of SW 33377, SW 68210 and SW 71425 thioxanthones on in vitro colony formation of freshly explanted human tumor cells. Investigational New Drugs. 16(3). 221–225. 8 indexed citations
17.
Wilkie, Michael P., et al.. (1997). Influences of temperature upon the postexercise physiology of Atlantic salmon(Salmo salar). Canadian Journal of Fisheries and Aquatic Sciences. 54(3). 503–511. 113 indexed citations
18.
Harvey, Kevin, et al.. (1987). Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media. British Journal of Cancer. 54(4). 587–594.
19.
Davidson, Karen, et al.. (1986). Combined Plasmacytoma and Squamous Cell Carcinoma. The Thoracic and Cardiovascular Surgeon. 34(6). 403–405. 3 indexed citations
20.
Hanley, Michael J. & Karen Davidson. (1981). Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. American Journal of Physiology-Renal Physiology. 241(5). F556–F564. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David L. Lattier Breakdown of academic impact, for papers by Midori Hashimoto Breakdown of academic impact, for papers by Öztürk Özdemir Breakdown of academic impact, for papers by Darcey Black Breakdown of academic impact, for papers by Cecil Hougie Breakdown of academic impact, for papers by Linus Chang Breakdown of academic impact, for papers by P. De Angelis Breakdown of academic impact, for papers by Taro Okazaki Breakdown of academic impact, for papers by T. Ishikawa Breakdown of academic impact, for papers by Florence Jouan
Rankless by CCL
2026